Review
Open access
Sep 2026
Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression
This review integrates evidence from tumor glycobiology, myeloid immunology, receptor signaling, experimental models, and therapeutic development to examine how C-type lectin receptors and Siglecs contribute to myeloid-mediated immune suppression.
Gonçalo Trindade, Angelina S. Palma, Catarina Brito
· Frontiers in Immunology · 2 citations